| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |